Limb regeneration involves several interrelated physiological processes in which a particular signalling pathway may play a variety of functions. Blocking the function of Wnt/β-catenin signalling during limb regeneration inhibits regeneration in axolotls (Ambystoma mexicanum). Limb development shares many features with limb regeneration, and Wnt/β-catenin activation has different effects depending on the developmental stage.
Introduction
The process of limb regeneration in urodeles may be divided into five stages that correspond to wound healing, dedifferentiation, blastema formation, morphogenesis and growth. During wound healing, the epithelial cells surrounding the wound migrate and cover the amputated surface; this epithelium later thickens to form the apical epidermal cap (AEC). Removal of this structure inhibits regeneration. In the phase of dedifferentiation, the cells of the distal end of the stump are released from their tissue organization and acquire a mesenchymal phenotype. These cells will proliferate and develop the blastema.
The morphogenesis process begins in this tissue when cells start to redifferentiate into the corresponding tissues. Later on, the limb grows to reach the size of a complete limb, which is impossible to distinguish from one that was never amputated (Nye et al., 2003; Carlson, 2007; Stocum and Cameron, 2011) .
In axolotl, Xenopus tadpole and zebrafish, limb regeneration is perturbed by inhibition of the Wnt/-catenin signalling pathway. For instance, in adult axolotls, misexpression of the inhibitor of the Wnt/β-catenin pathway Axin1 results in spike-like limbs with no digits (Kawakami et al., 2006) . Likewise, misexpression of the Wnt/-catenin signalling inhibitor Dkk1 in axolotl larvae results in complete blockage of limb regeneration, as demonstrated in a few cases (Kawakami et al., 2006) . In Xenopus, blocking the function of Wnt/β-catenin signalling by conditional expression of Dkk1 during early stages of tadpole limb regeneration inhibits this process, whereas inhibition of this signalling in froglet limb regeneration does not inhibit the usual spike formation (Yokoyama et al., 2007; Yokoyama 
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-4 -development (Saunders, 1948; Tschumi, 1957) . On the other hand, stabilization of β-catenin at early stages of limb development results in truncated limbs caused by early regression of the AER (Hill et al., 2006) , while at later stages it gives rise to skeletal abnormalities (Akiyama et al., 2004) . This suggests that proper limb development requires adequate spatial-temporal regulation of Wnt/β-catenin signalling.
Because limb regeneration is a complex process involving several physiological events at different regeneration stages, we speculated that Wnt/β-catenin activation may affect limb regeneration depending on the stage at which Wnt/β-catenin is activated. Hence, in this study, we evaluated the effect of chemical activation of Wnt/β-catenin signalling at different stages of limb regeneration. The results revealed two stages at which limb regeneration is affected by drug treatment. The first was when treatment was applied at the onset of limb regeneration before the formation of the blastema. This resulted in a lack of innervation and regeneration was inhibited. The second was when treatment was applied after blastema formation but before the onset of morphogenesis. This treatment led to skeletal disorganization. We also observed that Wnt agonist treatment increased cell proliferation at the blastema stage.
Experimental Procedures
Animal maintenance and treatment with hatched artemia cysts; animals older than one month were fed with adult artemia.
Axolotls measuring 5-6.5 cm were anaesthetized with 0.05% Tricaine (ethyl 3-aminobenzoate methanesulfonate salt, Sigma-Aldrich, St. Louis, MO, USA), and one forelimb was amputated at mid zeugopod. One micromolar Wnt agonist (2-amino-4-(3,4-(methylenedioxy) benzylamino)-6-(3-methoxyphenyl) pyrimidine) purchased from Calbiochem (Billerica, MA, USA) was diluted in filtered tap water. The animals were placed in the solution on different days after amputation depending on the experiment.
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Control animals were treated with the vehicle dimethyl sulfoxide (DMSO Later, collected limbs were stained in an Alcian blue/Alizarin red solution for 3 days. Limb skeletons were cleared in 1% KOH/20% glycerol and stored in 50% ethanol/50% glycerol.
Immunohistochemistry
The following antibodies and dilutions were used: 1:400 acetylated tubulin (T7451, Sigma- 
In situ hybridization of tissue sections
For in situ hybridization of Paraplast (Sigma-Aldrich)-embedded tissue sections (7 µm), the probe (sox9) was obtained based on previously described primers and sequence (Guimond et al., 2010) , and tissue sections were hybridized in situ according to Garciadiego-Cázares et al. (2004) .
Results
Chemical activation of Wnt/-catenin signalling during the wound-healing process inhibits limb regeneration
Active β-catenin was observed during limb regeneration (see Fig 1A, On this basis and given that the process of limb regeneration in urodeles may be divided into wound healing, dedifferentiation, blastema formation, morphogenesis and growth, we first evaluated the role of chemical activation of Wnt/-catenin during the wound-healing process. Amputated limbs were treated at 0, 24 or 48 hpa for 3 consecutive days with the Wnt agonist ( Fig. 1A ) and the skeletal morphology was analysed at 30 dpa, which is the normal duration for completion of the regenerated structure ( Fig 1B) . If required, the limb of treated animals was left to regenerate for longer. When animals were treated immediately after amputation, no regeneration of distal structures was observed in two of four cases (Fig. 1C) . The other two limbs regenerated normally though with a slight delay since regeneration was completed by 35 dpa, instead of the 30 dpa observed in controls.
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Wischin et al. Wischin et al. (submitted for publication)). In animals in which treatment began 48 h after amputation, limbs regenerated as normal (4/4), though with a slight delay (Fig. 1E ).
Animals in which treatment began 24 h after amputation were observed for 3 months; however, most were not able to recover and did not reform the missing limb structures (3/4; analysis showed disorganized thick collagen fibre deposition stained in blue (see Fig. 2B and C, compared with D, a non-amputated region of the same limb).
Chemical activation of Wnt/-catenin signalling on different days of the blastema formation process has differential effects on limb regeneration
On the basis that chemical activation of Wnt/-catenin signalling during the wound-healing process inhibited regeneration, we examined the effects during blastema formation in regenerating limbs. Amputated axolotls were treated at 7, 10 or 12 dpa for 3 days. When treatment began at 7 dpa, no abnormalities were observed in the final morphology (4/4), although a slight delay in blastema formation and a case with one fused carpal were detected (arrow in Fig. 1F ). Under these conditions, limbs were collected at 36 dpa. In contrast, the treatments that began at the end of blastema formation (10 and 12 dpa) resulted in skeletal malformations (3/3 and 3/3 respectively; (see Fig 3C- Wischin et al. (submitted for publication)).). Under these conditions, one regenerating limb developed only one digit and a small protuberance, which probably represented a second digit, no carpals were evident and the radius developed a bifurcation (arrow in Fig. 1G ). All animals treated at 12 dpa showed the same effects as observed at 10 dpa (Fig. 1H ).
Chemical activation of Wnt/-catenin signalling during morphogenesis retards limb regeneration but has no effect on final morphology
The Wnt agonist chemical treatment was also performed at the onset of morphogenesis (15 dpa). In this case, at around 35 dpa, all limbs presented all four digits (3/3), although in two of the limbs, the third digit had a missing phalange, and therefore it resembled digit 4. This
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-8 -digit was slender at the base of the metacarpal and seemed to be separated from the metacarpals (arrow in Fig. 1I ).
Amputated limbs unable to regenerate after chemical activation of Wnt/-catenin did not form a blastema and gave rise to non-innervated limbs
We evaluated the formation of blastema in amputated limbs at different times after chemical activation of Wnt/-catenin. The results showed that in control limbs at 2 dpa the epithelium had already covered the stump, and at 4 dpa wound closure was more evident.
At 7 dpa the blastema had begun to form and continued to grow thereafter. At 10 dpa the cartilage began losing its tissue organization, suggesting that dedifferentiation was occurring (white arrows in Fig. 3 ). At 15 dpa, limb regeneration in control animals advanced beyond blastema formation (Fig. 3) . In contrast, some amputated animals treated with the Wnt/-catenin agonist showed a delay in wound epithelialization at 2 dpa but by 4 dpa wound closure had been accomplished ( Fig. 3 ; 2/4). In contrast, no blastema was ever observed in limbs of Wnt agonist-treated animals ( Fig. 3; n=4) .
Remarkably, the morphology of the limbs of the treated animals that underwent dedifferentiation but never formed a blastema resembled that observed in the denervated amputated limb (Mescher and Tassava, 1975; Stocum, 2011) . For this reason, we evaluated the presence of innervation in amputated limbs of animals with the Wnt agonist using a 24 h post amputation time window treatment. As demonstrated by the presence of acetylated tubulin (Satoh et al., 2008) , the results showed that, at 3 dpa, control limbs were already innervated (4/4; Fig. 4 ). In contrast, in animals treated with the Wnt agonist, acetylated tubulin was never observed in any of the four limbs. To check for a possible delay in the innervation process, we also evaluated the innervation at 7 dpa under the same conditions, but, even then, no innervation was observed in any of the four limbs (Fig. 4) . These results suggest that the inhibition of limb regeneration observed in animals treated with the Wnt agonist before the formation of blastema might be due to a lack of innervation. (Fig. 5A, A` , A``, C).
Chemical activation of
During regeneration, the known role of the nerves is to induce cell proliferation (Mescher and Tassava, 1975; Stocum, 2011; Petrosky et al., 1980; Brockes, 1984) . We evaluated whether cell proliferation induced by chemical activation of Wnt/-catenin signalling was maintained if the regenerating limb was denervated. Therefore, limbs were denervated on 7 dpa and on 8 dpa the animals were treated with the Wnt agonist chemical for 24 h. We found that, even in denervated limbs, cell proliferation was observed in the epithelium and blastema during the stage of blastema formation in the Wnt agonist-treated animals ( Fig. 
5B, B`, B``, C).
Skeletal tissue organization is abnormal in animals treated with the Wnt agonist after the blastema has formed
As mentioned above, treatment with the Wnt agonist at stages of regeneration following blastema formation, before the onset of morphogenesis, resulted in limbs with fused skeletal elements and lack of ossification. Histological analysis performed at the mentioned stages showed disorganization of cartilage relative to control regenerated skeletal elements (Fig. 6A ). Some regions of cartilage did not show well-defined boundaries (arrowhead in Fig. 6A ). The cells of the presumptive interzone (dark blue arrow in Fig. 6A ) were not as compact as in the normal interzone (red arrows in Fig. 6A ). Cell nuclei were larger and the cell distribution was more homogeneous, although not in a columnar manner as occurs in a normal skeletal element (Fig. 6A ).
Chemical activation of Wnt/-catenin signalling does not affect Sox9 expression
Sox9 is a key transcription factor that promotes cartilage differentiation and is expressed at early stages during the molecular cascade of cartilage differentiation (Chimal-Monroy et al., 2003) . Wnt/β-catenin signalling is known to inhibit Sox9 expression during limb ACCEPTED MANUSCRIPT
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-10 -development (Akiyama et al., 2004; Chimal-Monroy et al., 2003; Day et al., 2005; ten Berge et al., 2005) . On this basis, some of the limb malformations observed in the amputated limbs treated after the formation of blastema could be attributed to the downregulation of Sox9. To evaluate this hypothesis, we submerged 12 dpa animals in the Wnt agonist for 24 h. Remarkably, we found no difference in Sox9 expression pattern between treated animals and controls (4/4; Fig. 6B ). In order to ensure that the lack of effect was not because the compound was unable to reach the blastema, we used beads embedded in 10 mM Wnt agonist, but again found no difference (3/3). This suggests that skeletal malformations might not be due to Sox9 regulation, but instead that genes downstream from Sox9 might be affected.
Discussion
The aim of this study was to determine the role of chemical activation of the Wnt/-catenin signalling pathway at different stages of limb regeneration. Blocking Wnt/-catenin signalling was previously shown to inhibit limb regeneration in species such as Xenopus tadpoles and zebrafish (Yokoyama, 2007; Yokoyama et al. 2011; Stoick-Cooper et al., 2007) . However, in axolotl, limb regeneration was only inhibited in 7% of the animals (Kawakami et al., 2006) . In contrast, in the present study, we observed that chemical activation of Wnt signalling at the wound-healing stage inhibited limb regeneration, and that when the treatment was administered after the establishment of the blastema, it caused disorganization of skeletal elements.
Because the Wnt agonist was administered in the water the effects of this drug was not only in regenerating limb, but also in the whole animal. However, it is possible to speculate that spite that this treatment was done to whole animal, Wnt agonist is playing physiological effects on limb regeneration more than toxic effects because after the treatments at different regenerating stages resulted on distinct limb phenotypes. Although we cannot rule out the possibility the effects by over-activation of Wnt signalling on other tissues or organs distinct to regenerating limb that may have an effect on limb regeneration.
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The chemical activation of Wnt signalling during the wound-healing process and particularly at 0 and 24 hpa inhibited limb regeneration. A possible mechanism is that Wnt signalling may inhibit keratinocyte migration giving rise to delay in the wound-healing process in treated animals. In addition, the disruption of collagen fibre organization visible under the epidermis after Wnt signalling activation supports our idea. Similar results were obtained after excessive Wnt/-catenin signalling in other systems (Stojadinovic et al., 2005) . In addition, chemical activation of the Wnt/-catenin signal at 24 hpa for 3 days resulted in a deficiency of innervation and, therefore, in inhibition of limb regeneration.
Interestingly, it is well known that fibrotic tissue can occur in denervated limbs, which normally do not regenerate (Kumar et al., 2007; Salley and Tassava, 1981) . Thus, the absence of innervation together with delay in the wound-healing process may explain inhibition of limb regeneration. Under these conditions, neither dedifferentiation nor blastema formation are observed (Mescher and Tassava, 1975; Stocum, 2011) . In the present work, we observed that inhibition of limb regeneration after activation of Wnt/β-catenin signalling occurred by inhibition of blastema formation as occurred after limb denervation.
It was interesting to find that when axolotls were denervated at stages of blastema formation such as 7 dpa or 8 dpa, cell proliferation did not occur. In contrast when animals were denervated 7 dpa or 8 dpa and then treated with the Wnt/ agonist for 24 h, cell proliferation did occur. These results suggest that when chemical activation of the Wnt/-catenin signal was carried out at blastema stages, cell proliferation was not affected.
When animals were treated after blastema formation but before the onset of morphogenesis, the regenerated limb presented many skeletal malformations. Such malformations were mainly fused skeletal elements, a lack of ossification, missing skeletal elements and a lack of tissue organization. These phenotypes are comparable to findings during limb development by constitutive activation of Wnt/β-catenin signalling under the promoter of Col2 for chondrocytes in developing mice (Akiyama et al., 2004; Tamamura et al., 2005) .
These data suggest that Wnt/β-catenin signalling regulates the morphogenesis of skeletal elements during limb regeneration in a similar way as occurs during limb development.
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